InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+13.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Balkin Michael, Chief Executive Officer. Officer active across 3 companies, notably Foresight Acquisition Corp.. In total, 8 disclosures have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €343k. History available since 19 January 2022. The latest transaction was disclosed on 16 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Balkin Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
93,527 sharesCommon StockSEC:0001437749-26-020103:0
100,000 sharesCommon StockSEC:0001437749-26-020103:1
Canonical exit: 7 Sept 2026 (T+90)
93,527 sharesCommon StockSEC:0001437749-26-012279:0
20,000 shares@ US$8.5362.7% of flowCommon StockSEC:0001437749-24-037709:0
Canonical exit: 16 Mar 2025 (T+90)
10,000 shares@ US$10.5837.3% of flowCommon StockSEC:0001437749-24-024617:0
Canonical exit: 3 Nov 2024 (T+90)
15,000 shares@ US$4.8377.3% of flowClass A Common StockSEC:0001213900-22-004459:0
Canonical exit: 28 Apr 2022 (T+90)
4,239 shares@ US$5.1022.7% of flowClass A Common StockSEC:0001213900-22-003127:0
Canonical exit: 19 Apr 2022 (T+90)
6,843,525 sharesClass A Common StockSEC:0000899243-21-039472:0
8 of 8 declarations
About Balkin Michael
Balkin Michael is Directeur Général and has filed 8 transactions in total. Across the 8 recent filings we hold, the activity consists of acquisitions, with EUR 343010 of buys and EUR 0 of sells, between 2021-10-06 and 2026-06-10. The filings concern Horizon Technology Finance Corp, P3 Health Partners Inc., and Foresight Acquisition Corp.
